IJOHNS  Vol.3 No.4 , July 2014
Kimura’s Disease—A Rare Cause of Head and Neck Swelling
Author(s) Kiran Rao*, Sudesh Kumar

Kimura’s disease (KD) is a chronic inflammatory disorder with unknown etiology, most commonly manifesting as painless unilateral cervical lymphadenopathy or subcutaneous masses in the head or neck region. The disease is characterized by a triad of painless subcutaneous masses in the head or neck region, blood and tissue eosinophilia, and markedly elevated serum immunoglobulin E levels. Kimura’s disease is an unusual vascular tumor that typically occurs at 20 to 30 years of age. There has been no documented case of malignant transformation; however, recurrence rates after excision may be as high as 25%. Surgery and medical therapy are useful for treatment. We present a 14 years old male developed a unilateral cervical mass associated with KD. It was a recurrence of disease. As a complete excisional resection of the mass already done 1 year back at some other centre, we decided to give medical treatment for Kimura’s disease.

Cite this paper
Rao, K. and Kumar, S. (2014) Kimura’s Disease—A Rare Cause of Head and Neck Swelling. International Journal of Otolaryngology and Head & Neck Surgery, 3, 200-204. doi: 10.4236/ijohns.2014.34037.
[1]   Lee, S. (2007) Kimura Disease. eMedicine. http://www.emedicine.com/derm/topic212.htm

[2]   Kimm, H.T. and Szeto, C. (1937) Eosinophilic Hyperplastic Lymphogranuloma, Comparison with Mikulicz’s Disease. Proc Chin Med Soc, 329.

[3]   Kimura, T., Yoshimura, S. and Ishikawa, E. (1948) On the Unusual Granulation Combined with Hyperplastic Changes of Lymphatic Tissues. Trans Soc Pathol Jpn, 37, 179-180.

[4]   Ben-Chetrit, E., Amir, G. and Shalit, M. (2005) Cetirizine: An Effective Agent in Kimura’s Disease. Arthritis & Rheumatology, 53, 117-118.

[5]   http://emedicine.medscape.com/article/1098777-treatment

[6]   Ramchandani, P.L., Sabesan, T. and Hussein, K. (2005) Angiolymphoid Hyperplasia with Eosinophilia Masquerading as Kimura Disease. British Journal of Oral and Maxillofacial Surgery, 43, 249-252.

[7]   Ohta, N., Fukase, S., Suzuki, Y., Ito, T., Yoshitake, H. and Aoyagi, M. (2011) Increase of Th2 and Tc1 Cells in Patients with Kimura’s Disease. Auris Nasus Larynx, 38, 77-82.

[8]   Katagiri, K., Itami, S., Hatano, Y., Yamaguchi, T. and Takayasu, S. (1997) In Vivo Expression of IL-4, IL-5, IL-13 and IFN-Gamma mRNAs in Peripheral Blood Mononuclear Cells and Effect of Cyclosporin A in a Patient with Kimura’s Disease. British Journal of Dermatology, 137, 972-977.

[9]   Sun, Q.F., Xu, D.Z., Pan, S.H., et al. (2008) Kimura Disease: Review of the Literature. Internal Medicine Journal, 38, 668-672.

[10]   Wang, D.Y., Mao, J.H., Zhang, Y., et al. (2009) Kimura Disease: A Case Report and Review of the Chinese Literature. Nephron Clinical Practice, 111, c55-c61.

[11]   Kung, I.T., Gibson, J.B. and Bannatyne, P.M. (1984) Kimura’s Disease: A Clinico-Pathological Study of 21 Cases and Its Distinction from Angiolymphoid Hyperplasia with Eosinophilia. Pathology, 16, 39-44.

[12]   Thomas, J., Jayachandran, N.V., Chandrasekhara, P.K., Rajasekhar, L. and Narsimulu, G. (2008) Kimura’s Disease—An Unusual Cause of Lymphadenopathy in Children. Clinical Rheumatology, 27, 675-677.

[13]   Chen, H., Thompson, L.D., Aguilera, N.S. and Abbondanzo, S.L. (2004) Kimura Disease: A Clinicopathologic Study of 21 Cases. The American Journal of Surgical Pathology, 28, 505-513.

[14]   Rajpoot, D.K., Pahl, M. and Clark, J. (2000) Nephrotic Syndrome Associated with Kimura Disease. Pediatric Nephrology, 14, 486-488.

[15]   Yoganathan, P., Meyer, D.R. and Farber, M.G. (2004) Bilateral Lacrimal Gland Involvement with Kimura Disease in an African American Male. Archives of Ophthalmology, 122, 917-919.

[16]   Park, S.W., Kim, H.J., Sung, K.J., Lee, J.H. and Park, I.S. (2012) Kimura Disease: CT and MR Imaging Findings. American Journal of Neuroradiology, 33, 784-788.

[17]   Kaneko, K., Aoki, M., Hattori, S., Sato, M. and Kawana, S. (1999) Successful Treatment of Kimura’s Disease with Cyclosporine. Journal of the American Academy of Dermatology, 41, 893-894.

[18]   Hernandez-Bautista, V., Yamazaki-Nakashimada, M.A., Vazquez-Garcia, R., Stamatelos-Albarran, D., Carrasco-Daza, D. and Rodriguez-Lozano, A.L. (2011) Treatment of Kimura Disease with Intravenous Immunoglobulin. Pediatrics, 128, e1633-e1635.

[19]   Hongcharu, W., Baldassano, M. and Taylor, C.R. (2000) Kimura’s Disease with Oral Ulcers: Response to Pentoxifylline. Journal of the American Academy of Dermatology, 43, 905-907.

[20]   Hareyama, M., Oouchi, A., Nagakura, H., et al. (1998) Radiotherapy for Kimura’s Disease: The Optimum Dosage. International Journal of Radiation Oncology * Biology * Physics, 40, 647-651.